Variations in the TSPO neuroinflammation-associated protein's structure correlates with worse survival outcomes for male glioblastoma brain cancer patients than females.
A combination of approved and novel therapeutics improved survival rates and reduced both tumor volume and growth for those suffering from glioblastoma brain cancer.
Cellular reprogramming of glioma cells into neural cells may be a promising treatment for glioblastoma brain cancer.
Researchers have identified specific proteins that drive the development of cancer stem cells. They report targeting and suppressing galectin1, in addition to radiation therapy, could be an effective treatment for glioblastoma brain cancer.
Researchers have successfully replicated an entire, viable glioblastoma brain tumor via 3D bioprinting. The bioprinted tumor includes a complex system of blood vessel-like tubes through which blood cells and drug molecules can flow, simulating a real tumor.
A new study reports cancer patients who frequently eat peanuts may be at increased risk of their cancer spreading. Researchers found Peanut agglutinin (PNA), a carbohydrate-binding protein that enters blood circulation after a peanut is eaten, interacts with endothelial cells to produce cytokines. Some of the cytokines are recognized promoters of cancer metastasis.
Cancer patients with vitamin D deficiency under palliative care reported a decreased need for opioids to control pain and reduced symptoms of fatigue when given vitamin D supplementation.